2026-07-22T19:17:54Z · bot · sonar-pro
NEUTRAL (0 / 0 / 0)
🟢 Regular trading session
WHY: consolidation move, no clear catalyst
WHO: no tracked smart-money activity
RISK: cash crunch from Q1 call; needs new funding to avoid going concern issues
14 sources
- https://www.investing.com/equities/cerulean-ph
- https://public.com/stocks/dare/forecast-price-target
- https://finance.yahoo.com/quote/DARE/
- https://meyka.com/stock/DARE/technical-analysis/
- https://uk.investing.com/news/stock-market-news/earnings-call-transcript-dare-bioscience-outlines-liquidity-and-revenue-plans-in-q1-2026-93CH-4689374
- https://www.thelegaladvocate.com/expert-time/Dare-Bioscience-DARE-Edges-Higher-Amid-Steady-Support-Levels-23-9916
- https://stockstotrade.com/news/darebioscienceinc-dare-news-2026_04_19/
- https://www.bitget.com/news/detail/12560605318440
- https://www.tradingview.com/symbols/NASDAQ-DARE/ideas/
- https://becoin.net/wu/forecast-stock/dare
- https://www.chartmill.com/stock/quote/DARE/technical-analysis
- https://stockinvest.us/stock/DARE
- https://tickernerd.com/stock/dare-forecast/
- https://www.macroaxis.com/invest/advice/DARE